MT-6035

MT-6035 is an investigational **PD-L1-targeted engineered toxin body** developed by **Molecular Templates** for oncology indications. It is a biologic fusion toxin therapeutic built on the company's **engineered toxin body** platform and is designed to bind **programmed death-ligand 1**, deliver a cytotoxic toxin payload to **directly kill PD-L1-expressing tumor cells**, and incorporate **antigen seeding** to enhance redirection of T-cell responses against tumors. Based on the provided context, it was being advanced for both **solid tumors** and **hematologic malignancies**, with plans to submit an IND in the second half of 2019.

Other names

PD-L1-targeted engineered toxin bodyPD-L-1-targeted engineered toxin bodyPD-L 1-targeted engineered toxin bodyPD-L1-targeted ETBPD-L-1-targeted ETBPD-L 1-targeted ETB